2-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 97%, 250mg

N-(2-methoxy-5-morpholinophenylcarbamothioyl)benzamide, 98%, 1g

4-(4-Ethoxyphenyl)-4-oxobutyric acid, 97.0%, 250mg

5,6-Dibromopicolinic acid, 98.0%, 100mg

tert-Butyl tetrahydropyridazine-1(2H)-carboxylate, 95.0%, 500mg

Acide trifluoroacétique, min 99,9%, 1L, emballage verre

4-(Chloromethyl)styrene (stabilized with TBC + ONP + 2-Nitro-p-cresol)>90.0%(GC)25g

2-[(2-amino-1,3-thiazol-4-yl)methyl]-1H-isoindole-1,3(2H)-dione, 95.0%, 250mg

4-Fluoro-3-(methylsulfonyl)phenylboronic acid pinacol ester, 98%, 500mg

3-Bromo-4-iodothiophene, 95.0%, 1g

1-CBZ-6-IODO-5-OXO-1,4-DIAZEPANE, 95.0%, 250mg

3-(Bromomethyl)pyridine hydrobromide, 95.0%, 1g

5-bromo-1-methyl-3-(trifluoromethyl)-1H-pyrazole, 95.0%, 10g